Recursion Pharmaceuticals Ownership | Who Owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Ownership Summary
Recursion Pharmaceuticals is owned by 65.31% institutional investors, 4.45% insiders, and 30.24% retail investors. Vanguard group is the largest institutional shareholder, holding 10.56% of RXRX shares. ARK Innovation ETF is the top mutual fund, with 4.39% of its assets in Recursion Pharmaceuticals shares.
RXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Recursion Pharmaceuticals | 65.31% | 4.45% | 30.24% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 47.19M | 10.56% | $193.00M |
| Blackrock funding, inc. /de | 38.87M | 8.70% | $158.97M |
| Ark investment management | 37.32M | 8.35% | $152.63M |
| Blackrock | 17.31M | 7.33% | $129.83M |
| Baillie gifford | 23.77M | 5.32% | $97.24M |
| State street | 18.27M | 4.38% | $89.15M |
| Softbank group | 14.67M | 3.51% | $71.58M |
| Kinnevik ab (publ) | 13.43M | 3.22% | $65.56M |
| Mubadala investment co pjsc | 12.99M | 3.11% | $63.37M |
| Geode capital management | 10.93M | 2.45% | $44.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kinnevik ab (publ) | 13.43M | 100.00% | $65.56M |
| Dcvc opportunity fund ii gp | 3.95M | 100.00% | $19.28M |
| Data collective iv gp | 5.94M | 42.65% | $28.99M |
| Mic capital management uk llp | 9.64M | 9.41% | $47.06M |
| Nan fung group | 595.29K | 4.87% | $2.91M |
| Novo | 7.93M | 2.49% | $38.70M |
| Pivotal bioventure partners investment advisor | 595.52K | 1.68% | $2.91M |
| Ark investment management | 37.32M | 1.01% | $152.63M |
| Nvidia | 7.71M | 0.98% | $37.61M |
| Carroll investors | 396.70K | 0.94% | $1.94M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 47.19M | 0.00% | 7.41M |
| Blackrock funding, inc. /de | 38.87M | 0.00% | 7.13M |
| State street | 18.27M | 0.00% | 7.09M |
| Norges bank | 5.74M | 0.00% | 5.74M |
| Blackrock | 17.31M | 0.00% | 4.99M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -7.73M |
| Fmr | 3.23M | 0.00% | -2.36M |
| Deerfield management company, l.p. (series c) | - | - | -2.31M |
| Novo | 7.93M | 2.49% | -1.74M |
| Morgan stanley | 5.66M | 0.00% | -1.63M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 5.74M | 0.00% | 5.74M | $23.47M |
| American century companies | 316.18K | 0.00% | 316.18K | $1.54M |
| Trexquant investment lp | 228.75K | 0.01% | 228.75K | $1.12M |
| State of new jersey common pension fund d | 124.67K | 0.00% | 124.67K | $509.89K |
| Wcg wealth advisors | 60.47K | 0.01% | 60.47K | $247.30K |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Nbc securities | -1.00 |
| Financial gravity asset management | -4.00 |
| Twin peaks wealth advisors | -4.00 |
| Bayforest capital | -7.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 281 | -19.25% | 291,943,780 | -10.14% | 65 | 1.08% | 149 | -16.29% | 69 | -14.81% |
| Sep 30, 2025 | 331 | -6.76% | 323,965,396 | 4.44% | 77 | 1.41% | 170 | -3.41% | 78 | -8.24% |
| Jun 30, 2025 | 341 | -2.01% | 308,955,617 | 7.04% | 74 | 1.44% | 170 | -16.67% | 85 | 21.43% |
| Mar 31, 2025 | 350 | 4.79% | 304,203,724 | -0.17% | 75 | 0.65% | 204 | 2.51% | 72 | 14.29% |
| Dec 31, 2024 | 308 | 10.79% | 289,638,352 | 11.01% | 102 | 1.20% | 181 | 16.77% | 56 | 12.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Innovation ETF | 23.20M | 4.39% | 352.51K |
| ARK Disruptive Innovation Full Composite | 20.52M | 3.88% | 2.24M |
| Scottish Mortgage Ord | 18.13M | 3.43% | -5.19K |
| State Street® SPDR® S&P® Biotech ETF | 16.71M | 3.16% | -89.40K |
| Vanguard Total Stock Mkt Idx Inv | 15.41M | 2.92% | -425.21K |
| ARK Genomic Revolution ETF | 12.55M | 2.38% | - |
| ARK Genomic Revolution | 11.67M | 2.21% | 792.66K |
| Vanguard Small Cap Index | 11.08M | 2.10% | -837.00 |
| Vanguard US Total Market Shares ETF | 8.01M | 1.99% | 1.01M |
| iShares Russell 2000 ETF | 9.13M | 1.73% | 6.23M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 09, 2026 | Khan Najat | CEO and President | Sell | $94.66K |
| Mar 03, 2026 | Borgeson Blake | - | Sell | $588.20K |
| Feb 19, 2026 | Gibson Christopher | - | Sell | $138.40K |
| Feb 18, 2026 | Taylor Ben R | Chief Financial Officer | Sell | $41.35K |
| Feb 04, 2026 | Gibson Christopher | - | Sell | $164.80K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 9 |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 7 |
RXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools